Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients ...

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.

Should you try a GLP-1 weight loss drug or surgery? Dr. Tim Woods of CoxHealth shares advice for both options.